Low Dose IL-2 Effective in Lupus
The 16th Annual La Paulee
Update on Myositis
Negotiation Skills for Rheumatologists
Physicians as a group are trained to have excellent clinical skills, but the difference between an average and extremely successful physician often comes down to factors outside of their ability to provide clinical care.
FEAR: A Perception of Fact In Spite of the Fiction
Pregnancy for patients with lupus has long been considered high risk and associated with both medical and obstetric complications, but outcomes have improved over the last 2 decades and continue to improve. The large decline in in-hospital maternal mortality was greater for lupus pregnancies than for non-lupus pregnancies. Findings from a retrospective cohort study are published in Annals of Internal Medicine.
Methotrexate and the Risk of Lung Disease
Rheumatology has a comprehensive overview of methotrexate (MTX) and the risk of lung injury, MTX-related pneumonitis and interstitial lung disease (RA-ILD) with rheumatoid arthritis (RA). Past reports suggest the frequence of MTX-pneumonitis to be between 0.3 and 11.6%; recent studies suggest it may be much lower.
Clinical criteria for the diagnosis of MTX pneumonitis (acute, reversible) and RA-ILD (chronic, progressive) are quite different and are reviewed in this article.
Best of EULAR 2018
Do Autoantibodies Drive Disease in Seropositive RA?
GoutOUT Surging in the Polls
6 Rheumatologists talk about the recent FDA Approval for over-the-counter GoutOut
Biosimilars in Rheumatology
Page Not Found
Sorry, this page wasn't found. If you expected to find it, try searching for it
Home
Whoops! You aren't allowed on this page
Sorry, but you aren't authorized to access this page. If you think this is a mistake, you can email us at info@rheumnow.com.